Literature DB >> 1632173

Ketamine anaesthesia in a patient with septic shock.

A Yli-Hankala1, M Kirvelä, T Randell, L Lindgren.   

Abstract

A 71-year-old male patient was operated on in a septic state (tachycardia, hypotonia, fever peaks, disorientation) because of an occluding tumour of the biliary tract. Ketamine was used as the main anaesthetic. Mean arterial pressure increased markedly and diuresis started during the anaesthesia. The inotropic support (dopamine, dobutamine, noradrenaline) could be reduced. Ketamine anaesthesia seemed to have a beneficial haemodynamic effect in septic shock.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632173     DOI: 10.1111/j.1399-6576.1992.tb03502.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

1.  Ketamine does not inhibit interleukin-6 synthesis in hepatic resections requiring a temporary porto-arterial occlusion (Pringle manoeuvre): a controlled, prospective, randomized, double-blinded study.

Authors:  Francisco Carlos Bonofiglio; Ernesto P Molmenti; Eduardo de Santibañes
Journal:  HPB (Oxford)       Date:  2011-07-22       Impact factor: 3.647

2.  Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats.

Authors:  Jie Sun; Xiao-Dong Wang; Hong Liu; Jian-Guo Xu
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 4.  Ketamine and peripheral inflammation.

Authors:  Marc De Kock; Sebastien Loix; Patricia Lavand'homme
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

5.  Comparison of efficacy of three subanesthetic doses of ketamine in allaying procedural discomfort during establishment of subarachnoid block: A randomized double-blind trial.

Authors:  V R Hemanth Kumar; Umesh Kumar Athiraman; Sameer M Jahagirdar; R Sripriya; S Parthasarathy; M Ravishankar
Journal:  Saudi J Anaesth       Date:  2015-01

6.  Effects of an intravenous ketamine infusion on inflammatory cytokine levels in male and female Sprague-Dawley rats.

Authors:  Haley F Spencer; Rina Y Berman; Martin Boese; Michael Zhang; Sharon Y Kim; Kennett D Radford; Kwang H Choi
Journal:  J Neuroinflammation       Date:  2022-04-04       Impact factor: 8.322

7.  Acute (R,S)-Ketamine Administration Induces Sex-Specific Behavioral Effects in Adolescent but Not Aged Mice.

Authors:  Alessia Mastrodonato; Ina Pavlova; Noelle Kee; Josephine C McGowan; J John Mann; Christine A Denny
Journal:  Front Neurosci       Date:  2022-04-21       Impact factor: 4.677

8.  Ketamine decreases inflammatory and immune pathways after transient hypoxia in late gestation fetal cerebral cortex.

Authors:  Eileen I Chang; Miguel A Zárate; Maria B Rabaglino; Elaine M Richards; Thomas J Arndt; Maureen Keller-Wood; Charles E Wood
Journal:  Physiol Rep       Date:  2016-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.